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First transapical implantation in Poland  
of the aortic valve bioprosthesis registered 
both for aortic stenosis and insufficiency
Pierwsze w Polsce przezkoniuszkowe wszczepienie protezy biologicznej  
zarejestrowanej dla niedomykalności i stenozy aortalnej
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An 86-year-old man (body mass index 26.2 kg/m2), suffering from severe symptomatic aortic stenosis, with a history of 
stable coronary artery disease, type 2 diabetes mellitus, hypertension, chronic obturatory pulmonary disease (COPD), and 
paroxysmal atrial fibrillation, who had undergone prostatectomy, sigmoidectomy for cancer, and biliary and pancreatic 
tracts stenting for a benign pancreatic mass, was admitted to our institution after the heart-team qualification for TAVI (Euro-
SCORE II 9.86%, STS score 31.202%). Six months prior to admission, he had been hospitalised in the cardiology ward and 
received percutaneous coronary intervention  with stent implantation to the left main coronary artery and balloon aortic 
valvuloplasty (BAV) as part of hybrid treatment. On admission, he presented with exertional dyspnoea (NYHA class III). 
Transthoracic echocardiogram demonstrated preserved left ventricular (LV) function (LVEF 45%) and aortic stenosis  
(AVA 1 cm2, AVAI 0.54 cm2, mean and maximal gradients: 31 mm Hg and 51 mm Hg, respectively) with mild aortic 
regurgitation (AR) and moderate mitral regurgitation. Contrast-enhanced computed tomography revealed tortuous iliac 
arteries, massive calcifications of the aortic valve and diffuse calcifications of aorta (Fig. 1A–D). The procedure was per-
formed with trans-oesophageal echocardiography (TOE) monitoring under general anaesthesia through a left antero-lateral 
mini-thoracotomy (sixth intercostal space). A 6 French catheter was placed in the right femoral artery. After exposure of 
the apex, two-layer pledgeted purse-string sutures were placed and epicardial electrodes implanted. After apical puncture, 
a soft J-tip guidewire was advanced into the descending aorta and exchanged using right Judkins for an extrastiff guidewire. 
A 12 French sheath was introduced into the LV and preprocedural 
BAV was performed using a 25 mm balloon (NuCLEUS, PFM Medical, 
Koeln, Germany) under rapid pacing, while the catheter and a 25 mm 
JenaValve were prepared. The delivery system was advanced into the 
LV and through the native valve into the ascending aorta. Feelers were 
positioned in Valsalva sinuses, and the valve was deployed. Additional 
BAV was required to obtain full unfolding and good valve function 
on angio graphy (Fig. 2). Periprocedural TOE revealed mild AR; in 
a follow-up TTE during the hospitalisation it subsided completely. In 
electrocardiography, a transient left bundle branch block was observed, 
but from 24 h postoperatively to 
discharge, no conduction blocks 
were recorded. Postoperatively, 
four packed red blood cells and 
one platelets concentrate transfu-
sions were administered. Inten-
sive ventilatory rehabilitation was 
applied for exacerbated COPD. 
Follow-up echocardiography re-
vealed no AR. Transient psychotic 
symptoms were observed, but 
they subsided before discharge on 
postoperative day 17. 
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Figure 2. Angiogram showing 
JenaValve prosthesis in position 
after successful implantation
Figure 1. Computed tomography angiograms show-
ing tortuous iliac arteries (A, B), calcifications of 
aortic valve (C) and diffuse calcifications of aorta (D) 
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